First human test for new blood pressure shot halted early
Disease control
Terminated
This was a very early, first-in-human study to check the safety of a new experimental drug, ART101, for high blood pressure. The goal was to give single, increasing doses to a small group of adults with hypertension and monitor them closely for side effects and how the drug moves…
Phase: PHASE1 • Sponsor: Arnatar Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC